For instance, the elevated level of circHIPK3 can promote gemcitabine (GEM) resistance in pancreatic cancer cells by targeting RASSF1 via miR-330-5p [52], while the overexpression of circHIPK3 in bladder cancer (BC) leads to GEM sensitivity [86]. This evidence concerns the gene RASSF1 and familial pancreatic carcinoma.